Services

61. Clinical Pharmacology 5/17/2011
    Clinical Pharmacology — Scientific Steps in Safety, To move from Phase I to Phase IIa and then to guide the dosing-regimen design for Phase III studies.
62. Phase I/IIa 5/17/2011
    You need to safely advance your drug candidate through phase I/IIa. The key to achieving this objective — on time — is to focus on maximizing critical data through strategic study design.
63. Project Management 12/30/2008

    Aptuit’s unique approach features centralized project management that helps navigate the process as a molecule or compound advances from inception through clinical development. Aptuit assigns a Project Manager with relevant, in-depth experience as the client’s primary point of contact.

64. Toxicology And Safety Pharmacology 10/1/2008
    Ricerca can demonstrate the safety of your drug candidate and provide the data required to support your IND. Typically, we perform 14- or 28-day toxicity studies in two or more animal species.
65. Regulatory Consulting and Review 6/26/2006
    Drug Development Services- Camargo’s expertise in regulatory affairs and submissions runs the drug development gamut: pre-IND and IND preparation and submissions; pre- and post-IND and NDA meetings with the FDA; and the preparation and submission of NDAs, ANDAs, and 505(b)(2) NDAs
66. Phase I - IV Clinical Development Services 6/26/2006
    At Camargo Pharmaceutical Services, our comprehensive clinical development competencies are marked by the efficiency and performance excellence that sets us apart in the drug development services field
67. Pre-Phase I Services 6/26/2006
    Drug Development Services- Camargo Pharmaceutical Services is a one-stop source for pre-Phase I drug development services, including
68. Marketing Applications

    Setting the highest standards for marketing applications
    A marketing application is the most critical milestone in your clinical research program. Quality applications can accelerate time to market, bring the benefit of new treatments to patients sooner, maximize research investments, and conserve patent life – demanding a partner with an insider’s understanding of the regulatory landscape and a proven track record for success.

69. Clinical Data Management

    Fast, flexible, and quality clinical data management
    Clinical Data Management has undergone a rapid evolution, and the tools and processes of the last decade are not enough to ensure high-quality clinical data anymore. Grounded in a foundational knowledge of clinical data management best practices, our experts have developed system-agnostic, in-house data visualization and statistically-based anomaly detection and trend identification tools to provide actionable, risk-based insights and ensure the timely and accurate review of clinical trial data.